Adicet Bio to Host Conference Call to Provide Updates on its Clinical Pipeline and Corporate Outlook
03 Enero 2024 - 3:01PM
Business Wire
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology
company discovering and developing allogeneic gamma delta T cell
therapies for cancer, today announced that the Company will host a
conference call and webcast presentation on Thursday, January 4,
2024 at 8:00am ET to provide an update on its clinical pipeline and
corporate outlook.
Conference Call and Webcast Event
The live webcast of the presentation can be accessed by
registering under “Presentations & Events” in the investors
section of the Company’s website at https://www.adicetbio.com. Upon
registration, all participants will receive a confirmation email
with a unique passcode to provide access to the webcast event. To
participate via telephone, please join by dialing 888-788-0099
(domestic) or 312-626-6799 (international) and referencing the
conference ID 918 2940 8885. An archived replay will be available
for 30 days following the presentation. The archived webcast will
be available on the Company's website beginning approximately two
hours after the event.
About Adicet Bio, Inc.
Adicet Bio, Inc. is a clinical stage biotechnology company
discovering and developing allogeneic gamma delta T cell therapies
for cancer. Adicet is advancing a pipeline of “off-the-shelf” gamma
delta T cells, engineered with chimeric antigen receptors (CARs) to
enhance selective tumor targeting and facilitate innate and
adaptive immune response for durable activity in patients. For more
information, please visit our website at
https://www.adicetbio.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240103490668/en/
Adicet Bio, Inc. Investor and Media Contacts Anne
Bowdidge abowdidge@adicetbio.com Janhavi Mohite Stern Investor
Relations, Inc. 212-362-1200 janhavi.mohite@sternir.com
Adicet Bio (NASDAQ:ACET)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Adicet Bio (NASDAQ:ACET)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024